Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells

被引：10
|
作者：
Banoth, Balaji [1 ]
Cassel, Suzanne L. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 140卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Nucleotide-binding leucine-rich repeat receptor family pyrin domain containing protein 3; Bruton tyrosine kinase; ibrutinib;
D O I：
10.1016/j.jaci.2017.03.041
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：985 / 987
页数：3
相关论文
共 50 条
  • [41] Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells
    Mahajan, S
    Vassilev, A
    Sun, N
    Ozer, Z
    Mao, C
    Uckun, FM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (33) : 31216 - 31228
  • [42] Infiltrating Bruton's tyrosine kinase expressed B cells effects on prostate cancer metastasis
    Byrd, Crystal
    Liou, Geou-Yarh
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Bruton's Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies
    Lou, Yan
    Owens, Timothy D.
    Kuglstatter, Andreas
    Kondru, Rama K.
    Goldstein, David M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4539 - 4550
  • [44] Role of Bruton's tyrosine kinase in B cells and malignancies (vol 17, 57, 2018)
    Singh, Simar Pal
    Dammeijer, Floris
    Hendriks, Rudi W.
    MOLECULAR CANCER, 2019, 18 (1)
  • [45] Bruton's Tyrosine Kinase Promotes Persistence of Mature Anti-Insulin B Cells
    Bonami, Rachel H.
    Sullivan, Allison M.
    Case, James B.
    Steinberg, Hannah E.
    Hoek, Kristen L.
    Khan, Wasif N.
    Kendall, Peggy L.
    JOURNAL OF IMMUNOLOGY, 2014, 192 (04): : 1459 - 1470
  • [46] Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies
    Campbell, Robert
    Chong, Geoffrey
    Hawkes, Eliza A.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (04)
  • [47] Inhibition Of Bruton's Tyrosine Kinase Selectively Prevents Antigen Activation Of B Cells And Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis
    Torke, S.
    Pretzsch, R.
    Haeusler, D.
    Grenningloh, R.
    Boschert, U.
    Brueck, W.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 60 - 61
  • [48] BRUTON TYROSINE KINASE IS TYROSINE-PHOSPHORYLATED AND ACTIVATED IN PRE-B LYMPHOCYTES AND RECEPTOR-LIGATED B-CELLS
    AOKI, Y
    ISSELBACHER, KJ
    PILLAI, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) : 10606 - 10609
  • [49] Prolonged Inhibition of BCR Signaling and Suppression of B Cell Lymphoma through Irreversible Inhibition of Bruton's Tyrosine Kinase.
    Evans, Erica
    Sheets, Michael
    Bernard, Hugues
    Martin, Thia St.
    Nacht, Mariana
    Tester, Rich
    Jewell, Chuck
    Mazdiyasni, Hormoz
    Petter, Russell
    Westlin, William
    Singh, Juswinder
    BLOOD, 2008, 112 (11) : 904 - 904
  • [50] Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase
    Wasif N. Khan
    Immunologic Research, 2001, 23 : 147 - 156
12345